MDT Medtronic plc Loading... : Bullish and Bearish Analyst Opinions
From JNJ earnings callsLoading chart...
Top Calls
Feed
08:30
Jul 15
Jul 15
JNJ's electrophysiology growth was depressed ~400bps due to inventory destocking in China, suggesting a broader channel correction that may affect peers with China exposure. — If this is an industry-wide destocking, other medtech companies (Boston Scientific, Medtronic) may similarly see an EP growth headwind in coming quarters, beyond just JNJ.
MED
08:30
Apr 14
Apr 14
JNJ anticipates second-half headwinds from volume-based procurement (VBP) in China for electrophysiology products, already factored into guidance. — China VBP expansion into electrophysiology will pressure pricing for all players, including Medtronic and Boston Scientific, and is a leading indicator of regulatory cost-containment actions in a key market.
MED
08:30
Jan 21
Jan 21
JNJ's EP business growth accelerated to 9.5% in Q4 driven by Varipulse, but competitive PFA pressures remain, indicating ongoing share battles in the pulsed-field ablation market. — Varipulse adoption (40k+ cases) shows JNJ is regaining EP share, but 'competitive pressures' signal Medtronic and Boston Scientific are not ceding ground; a multi-year battle for PFA leadership is underway.
MED
About MDT Analyst Coverage
Buzzberg tracks MDT (Medtronic plc) across 1 sources. 0 bullish vs 0 bearish calls from 3 analysts. Sentiment: evenly split. 3 total trade ideas tracked. Latest voices: Tim Schmidt, Joe Walk, Joe Wolk.